Fig. 3From: Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetesDevice-oriented clinical endpoint in the 2 stents. a Overall cohort; b adjusted cohort; BP-SES biodegradable polymer sirolimus-eluting stent, DP-EES durable polymer everolimus-eluting stentBack to article page